Roger Dansey - 06 Nov 2025 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Roger Dansey
Issuer symbol
NRIX
Transactions as of
06 Nov 2025
Transactions value $
$0
Form type
4
Date filed
10 Nov 2025, 07:19
Previous filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DANSEY ROGER D Director C/O NURIX THERAPEUTICS, INC., 1700 OWENS STREET, SAN FRANCISCO /s/ Daniel Burbach, as Attorney-in-Fact for Roger Dansey 2025-11-10 0001741836

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Director Stock Option (right to buy) Award $0 +50K $0.00 50K 06 Nov 2025 Common Stock 50K $12.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares monthly beginning December 6, 2025 until the option is fully vested on November 6, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date.